ACS Dobfar S.p.A. Labesfal - Almiro Laboratories, S.A.
PolandAll medications by this manufacturer
-
Meropenem kabi
Form: powder for preparation of solution for injection or infusion
Active substance Dosage meropenem 570 mg ATC: J01DH02
-
Meropenem kabi
Form: powder for preparation of solution for injection or infusion
Active substance Dosage meropenem 1140 mg ATC: J01DH02